JPS53149974A - Nn*44*22pyrazolee1111*arbonamide** ethyl**benzenesulfonyl*urea process for preparing same and medical composition containing same - Google Patents

Nn*44*22pyrazolee1111*arbonamide** ethyl**benzenesulfonyl*urea process for preparing same and medical composition containing same

Info

Publication number
JPS53149974A
JPS53149974A JP16094077A JP16094077A JPS53149974A JP S53149974 A JPS53149974 A JP S53149974A JP 16094077 A JP16094077 A JP 16094077A JP 16094077 A JP16094077 A JP 16094077A JP S53149974 A JPS53149974 A JP S53149974A
Authority
JP
Japan
Prior art keywords
same
arbonamide
benzenesulfonyl
ethyl
composition containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP16094077A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5633391B2 (enExample
Inventor
Buruzozousukii Zudojisurau
Magieruka Sutanisurau
Angierusukii Sutefuan
Yanikuki Sutanisurau
Uoyushikousukii Kuzesurau
Yakubousukii Zenon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akademia Medyczna
Original Assignee
Akademia Medyczna
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akademia Medyczna filed Critical Akademia Medyczna
Publication of JPS53149974A publication Critical patent/JPS53149974A/ja
Publication of JPS5633391B2 publication Critical patent/JPS5633391B2/ja
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/16Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP16094077A 1976-12-31 1977-12-28 Nn*44*22pyrazolee1111*arbonamide** ethyl**benzenesulfonyl*urea process for preparing same and medical composition containing same Granted JPS53149974A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL1976195000A PL106114B1 (pl) 1976-12-31 1976-12-31 Sposob wytwarzania nowych n-(4-/2-/pirazolo-1-karbonamido/-etylo/-benzenosulfonylo)-mocznikow

Publications (2)

Publication Number Publication Date
JPS53149974A true JPS53149974A (en) 1978-12-27
JPS5633391B2 JPS5633391B2 (enExample) 1981-08-03

Family

ID=19980256

Family Applications (1)

Application Number Title Priority Date Filing Date
JP16094077A Granted JPS53149974A (en) 1976-12-31 1977-12-28 Nn*44*22pyrazolee1111*arbonamide** ethyl**benzenesulfonyl*urea process for preparing same and medical composition containing same

Country Status (6)

Country Link
US (1) US4153710A (enExample)
JP (1) JPS53149974A (enExample)
DE (1) DE2759241C3 (enExample)
GB (1) GB1592380A (enExample)
PL (1) PL106114B1 (enExample)
SU (2) SU789520A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL370989A1 (en) * 2001-12-21 2005-06-13 Novo Nordisk A/S Amide derivatives as gk activators
MXPA05000130A (es) * 2002-06-27 2005-02-17 Novo Nordisk As Derivados de aril-carbonilo como agentes terapeuticos.
PL1723128T3 (pl) * 2004-01-06 2013-04-30 Novo Nordisk As Pochodne heteroarylowe mocznika oraz ich zastosowanie jako aktywatory glukokinazy
ATE547396T1 (de) * 2005-07-08 2012-03-15 Novo Nordisk As Dicycloalkylcarbamoyl-harnstoffe als glucokinase- aktivatoren
KR20080024211A (ko) * 2005-07-08 2008-03-17 노보 노르디스크 에이/에스 디시클로알킬 우레아 글루코키나제 활성제
US7884210B2 (en) 2005-07-14 2011-02-08 Novo Nordisk A/S Ureido-thiazole glucokinase activators
US8138185B2 (en) * 2007-01-09 2012-03-20 Novo Nordisk A/S Urea glucokinase activators
EP2099777B1 (en) 2007-01-11 2015-08-12 Novo Nordisk A/S Urea glucokinase activators
EP4487909A3 (en) 2018-06-12 2025-03-19 vTv Therapeutics LLC Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs
US12391658B2 (en) 2020-02-18 2025-08-19 Vtv Therapeutics Llc Sulfoxide and sulfone glucokinase activators and methods of use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH516578A (de) * 1967-11-02 1971-12-15 Bayer Ag Verfahren zur Herstellung von heterocyclische Acylaminogruppen enthaltenden Arylsulfonylharnstoffen mit blutdrucksenkender Wirkung
US3668215A (en) * 1967-11-25 1972-06-06 Bayer Ag Aryl-sulphonyl-semicarbazides containing heterocyclic acylamino groups
US3887709A (en) * 1971-09-16 1975-06-03 Zdzislaw Brzozowski 2-Pyrazoline-1-carboxamide sulfonamide derivatives useful as hypoglycemic agents
CH593263A5 (enExample) * 1974-02-22 1977-11-30 Hoffmann La Roche
US4007201A (en) * 1975-05-30 1977-02-08 Kyorin Pharmaceutical Co. Ltd. Novel pyrazole derivatives

Also Published As

Publication number Publication date
DE2759241B2 (de) 1980-07-24
PL106114B1 (pl) 1979-11-30
US4153710A (en) 1979-05-08
DE2759241C3 (de) 1981-05-21
GB1592380A (en) 1981-07-08
PL195000A1 (pl) 1978-11-20
SU816398A3 (ru) 1981-03-23
JPS5633391B2 (enExample) 1981-08-03
DE2759241A1 (de) 1978-07-06
SU789520A1 (ru) 1980-12-23

Similar Documents

Publication Publication Date Title
JPS52122632A (en) Medical composition and process for preparing same
JPS5318557A (en) Novel aminoalkylfuran derivatives* their preparation and medical composition containing same
JPS5315436A (en) Fluorooterpolymer contained hair fixation compound and process for hair fixation
GB1556919A (en) Piperidylindole derivatives processes for preparing them and pharmaceutical compositions containing them
JPS52125193A (en) Indolysine derivatives process for preparing same and medicine containing same
JPS52151194A (en) Novel adenine derivatives process for preparing same and medical composition containing same
JPS53149974A (en) Nn*44*22pyrazolee1111*arbonamide** ethyl**benzenesulfonyl*urea process for preparing same and medical composition containing same
JPS5283397A (en) 1*44benzoxazine and 1*44benzothiazine cyclic derivatives process for preparing same and medical composition having antiidepression activity containing same
JPS5277092A (en) Spiro*1*33dioxolanee4*3**quinucridine process for preparing same and medical composition containing same
JPS5318526A (en) Phenoxyyalkanone acid derivatives*process for preparation thereof and composition containing same
JPS5287192A (en) 77aminothiazolylacetoamid cephalospolanate derivatives process for preparing same and pharmaceutical composition
JPS5384973A (en) 1*3*44oxadiazole process for preparing same and application thereof
JPS53121789A (en) Penicilline process for preparing and medical composition containing same
JPS539749A (en) Process for preparing 2*22dimethyll 33isobutyllcyclopropionate derivatives and preparation thereof and harmful living removing agent containing same
HU173881B (hu) Sposob poluchenija n-skobka-1h-benzimidazol-2-il-skobka zakryta-karbamatov i farmacevticheskikh kompozicijj soderzhahhikh ikh aktivnymi agentami
JPS543036A (en) Alphaavinyl and ethynyll3*44 disubstituteddphenylalanine composition thereof and process for preparing same
JPS545946A (en) 4*66diioo*aminoglycosile**1*33 diaminocyclitols process for preparing same and application thereof
JPS52156869A (en) Production of benzomorphane derivatives and medical composition containing same
JPS5277081A (en) Pfnicillins process for preparing same and medical composition containing same
JPS53101366A (en) 1*33disubstituted urea or 22thiourea and process for preparing same
JPS5295690A (en) Derivatives of 33carbamoyloxymethyll 77*aminoo44thiazolylacetoamide* cephalospolanate process for preparing same and pharmaceutical compound
JPS52151104A (en) Stabilizing composition for 1*1*11trichloroethane and process for preparing same
GB1532734A (en) 17-spirosultine derivatives and the corresponding ypsilon-hydroxy-acid derivatives of androst-4-en-3-one processes for preparing them and pharmaceutical compositions containing them
JPS53116364A (en) Hydroxylize 1alphaa2alphaa methylenesteroid process for preparing same and medicine having antiandrogen effect containing same
JPS5285107A (en) Novel aminothioderivatives process for preparing same and insecticide containing derivatives as efeective component